Literature DB >> 27587317

Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations.

Job F M van Boven1, Dermot Ryan2, Michelle N Eakin3, Giorgio W Canonica4, Aji Barot5, Juliet M Foster6.   

Abstract

Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescribed therapy, (2) implementation as prescribed, and (3) subsequent persistence. Medication adherence remains suboptimal in most patients with long-term respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Interventions have been shown to effectively improve treatment initiation, implementation, and persistence when delivered at the health care professional level or the system level, but demonstration of the cost-effectiveness of these interventions is necessary to ensure their widespread use. This review summarizes how health care professionals can intervene to improve medication adherence in patients with asthma and COPD, provides some examples of effective primary care interventions, and illustrates some of the challenges to optimal implementation arising from cost-effectiveness modeling. Improving adherence is shown to be an economically viable treatment option for patients with asthma and COPD, but there are differences in the health economics pertaining to each condition and setting that can affect whether an intervention is considered cost-effective. Targeting adherence interventions at patients with the greatest to gain, and tailoring them to individual patient needs, may help to optimize cost-effectiveness ratios and improve the probability of positive reimbursement decisions, systemwide implementation, and resultant health benefits.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; COPD; Health care professionals; Implementation; Initiation; Medication adherence interventions; Persistence; cost-effectiveness

Mesh:

Substances:

Year:  2016        PMID: 27587317     DOI: 10.1016/j.jaip.2016.03.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  21 in total

1.  Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations.

Authors:  R Brett McQueen; Danielle N Sheehan; Melanie D Whittington; Job F M van Boven; Jonathan D Campbell
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

2.  Using a knowledge translation framework to identify health care professionals' perceived barriers and enablers for personalised severe asthma care.

Authors:  Eleanor C Majellano; Vanessa L Clark; Rebecca F McLoughlin; Peter G Gibson; Vanessa M McDonald
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

3.  Investigating the cost implications of including all respiratory medicines in PCRS schemes.

Authors:  Jackie O'Dwyer; Aileen Murphy
Journal:  Ir J Med Sci       Date:  2018-02-01       Impact factor: 1.568

Review 4.  Solving the mystery of the yellow zone of the asthma action plan.

Authors:  Samir Gupta; Alan Kaplan
Journal:  NPJ Prim Care Respir Med       Date:  2018-01-11       Impact factor: 2.871

Review 5.  Digital technologies and adherence in respiratory diseases: the road ahead.

Authors:  John D Blakey; Bruce G Bender; Alexandra L Dima; John Weinman; Guilherme Safioti; Richard W Costello
Journal:  Eur Respir J       Date:  2018-11-22       Impact factor: 16.671

6.  Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma.

Authors:  Simon Wan Yau Ming; John Haughney; Dermot Ryan; Shishir Patel; Matthias Ochel; Martina Stagno d'Alcontres; Susannah Thornhill; Janwillem W H Kocks; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2019-02-08       Impact factor: 2.871

7.  Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients.

Authors:  Jee-Ae Kim; Min Kyoung Lim; Kunil Kim; JuHee Park; Chin Kook Rhee
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 8.  Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers.

Authors:  Evalyne M Jansen; Susanne J van de Hei; Boudewijn J H Dierick; Huib A M Kerstjens; Janwillem W H Kocks; Job F M van Boven
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

9.  Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD.

Authors:  Marc Miravitlles; Alicia Marín; Alicia Huerta; David Carcedo; Alba Villacampa; Jaume Puig-Junoy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-10

Review 10.  Improving adherence in chronic airways disease: are we doing it wrongly?

Authors:  Gráinne d'Ancona; John Weinman
Journal:  Breathe (Sheff)       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.